Allos Therapeutics’ 4Q loss widens on costs (AP via Yahoo! News)
1 Mar 2010Biotechnology company Allos Therapeutics Inc. said Monday its fourth-quarter loss widened on higher costs associated with sales of the cancer drug Folotyn.
Read the original here:
Allos Therapeutics’ 4Q loss widens on costs (AP via Yahoo! News)
Comment Form
About Biolexis
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.
Biotech
Categories
- Biotechnology News (4129)
Archives
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- November 2008
- October 2008
- August 2008
- July 2008
- June 2008
- April 2008
- February 2008
- January 2008
- December 2007
- August 2007
- July 2007
- June 2007
- April 2007
- February 2007
- December 2006
- September 2006
- August 2006
- Impact Of Demonstration Of Vermy Composting For The Benefit Of Sc …
- » Generex Biotechnology Corp. is Today's Focus Stock on …
- Biotech Grants – Biotechnology Funding – Biotechnology Grants …
- Regenerating damaged tissues: Bioscaffolds promote growth of joints in rabbits
- The Basics of Modern Biotechnology | The World of Snark
- Generex Pipeline Review by R J Steffens: Previewing Generex …
- Biotechnology in India | Bio Technology
- Molecular Biology as a career | Bio Technology
- Generex Biotechnology Corp. is Today’s Focus Stock on MicroStockProfit.com
- new job search» Blog Archive » The Future of Biotechnology Jobs in …
